GmbH & Co. KG was founded in August 2007 by the dermatologist Dr. Ulrich Matthes. At the same time he was the Managing Owner of PPM-Medical Holding GmbH.
is providing highest quality medicinal products to healthcare systems.
is giving advice to others in regulatory matters.
is acting CRO and Legal Representative Services for selected Partners.
20 mg and 40 mg was marketed from 2008 until early in 2015.
At present, further drugs in various indications are under preparation
At FLEXOPHARM® the individual – whether staff member, business partner, customer, supplier or representative of a government agency – is always treated fairly. The contentment of the patients treated with our medicinal products is our prime concern.
FLEXOPHARM® commits to meet all statutory and regulatory requirements. The actions of its employees, advisors and Advisory Council members are intended to benefit human beings and not primarily institutions.
The work of FLEXOPHARM® and its employees is aimed at economical patient care of the highest quality. FLEXOPHARM® makes every effort to find and implement possibilities for optimizing its products – such as new formulations and/or new indications.
The Scientific Advisory Board and company's advisors are sharing knowledge and thus are safeguarding the quality our work.